Format

Send to:

Choose Destination
See comment in PubMed Commons below
Oncology (Williston Park). 1992 Mar;6(3):51-8; discussion 58, 63-6.

Bone marrow transplantation for genetic disorders.

Author information

  • 1Bone Marrow Transplant Program, Hackensack Medical Center, New Jersey.

Abstract

Allogeneic bone marrow transplantation has been successfully utilized to correct the lymphoid and/or hematopoietic abnormalities characterizing a wide array of lethal genetic disorders. Examples include severe combined immunodeficiency, Wiskott-Aldrich syndrome, thalassemia major, sickle cell anemia, and several types of lysosomal storage diseases. Most marrow transplant recipients require preparation with myeloablative doses of chemotherapy, with or without additional radiation therapy, to ensure engraftment of allogeneic marrow. This approach has dramatically changed the long-term outlook for many children with otherwise lethal disorders.

PMID:
1533145
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk